Sign in Subscribe
Food supply

Boehringer Ingelheim Secures Approval for Bird Flu Vaccine in the Philippines

Strategic Insights

— 1 min read

The Philippines has received a critical boost in its fight against avian influenza, also known as bird flu, with the approval of the first vaccine against the deadly disease. Boehringer Ingelheim Philippines secured the approval from the Philippine Food and Drug Administration (FDA) for its Volvac B.E.S.T. AI + ND vaccine, which can be administered to healthy chickens as early as 10 days old. The vaccine has been proven effective in reducing bird flu outbreaks in other countries, with modeling studies suggesting it can lower bird culling by more than 90 percent during outbreaks.

Key Takeaways:

  • The Philippine Food and Drug Administration (FDA) has approved the country's first vaccine against avian influenza, also known as bird flu, developed by Boehringer Ingelheim Philippines.
  • The vaccine, Volvac B.E.S.T. AI + ND, can be administered to healthy chickens as early as 10 days old and provides immunity within 10 to 14 days.
  • Vaccination has been shown to be an effective layer of defense against bird flu, limiting virus transmission, protecting flocks, and reducing the economic fallout of outbreaks.
  • Globally, vaccination has reduced bird flu outbreaks, with France experiencing a decrease from over 300 to 10 in one year, and modeling studies suggesting it can lower bird culling by more than 90 percent during outbreaks in China.
  • The disease remains a persistent threat to the poultry sector, leading to widespread culling, transport restrictions, and trade disruptions that jeopardize food supply.
  • Nine provinces and 138 barangays in the Philippines remain affected by bird flu, according to the latest government data.

Statistics:

  • The vaccine has been proven effective in reducing bird flu outbreaks, with modeling studies suggesting it can lower bird culling by more than 90 percent during outbreaks.
  • In the Philippines, nine provinces and 138 barangays remain affected by bird flu, according to the latest government data.
  • The Philippine Food and Drug Administration (FDA) has approved the country's first vaccine against avian influenza, developed by Boehringer Ingelheim Philippines.

Sources:

  • Boehringer Ingelheim Philippines
  • Philippine Food and Drug Administration (FDA)
  • Department of Agriculture (DA)

Read more